MA7-25299-69353
1 vaccination
5 coded responses
6 check-ins
5 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 160 / PA
- Registered
- 2020-12-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Dose 1 — Pfizer-BioNTech
-
2020-12-20
Registered in v-safe
-
2020-12-20
Survey response — days 1–6 daily, dose 1MedDRA: Hyperhidrosis, Oropharyngeal pain — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Sore throat, sweatingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-20
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2020-12-21
Survey response — days 1–6 daily, dose 1MedDRA: Hyperhidrosis, Oropharyngeal pain — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Excessive sweating, sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-21
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2020-12-22
Survey response — days 1–6 daily, dose 1MedDRA: Hyperhidrosis, Oropharyngeal pain — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Sweating, sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-22
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2020-12-23
Survey response — days 1–6 daily, dose 1MedDRA: Hyperhidrosis, Oropharyngeal pain — Feeling: Fair · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Sore throat, sweatingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-23
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-05
-
2021-12-19
Survey response — 12 months, dose 1MedDRA: Cardiac disorder, Migraine, Nasopharyngitis, Office visit — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Frequent migraines, more susceptible to colds, frequent heart issues · Healthcare visit (other): Doctors officeMedDRA releases: 2024-11 · check-in free text available
-
2021-12-19
Report sent to call center — 12 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-12-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech |
Call center
5 call center cases
1 unsuccessful · 4 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Sore throat, sweating
Systemic reaction (other): Excessive sweating, sore throat
Systemic reaction (other): Sweating, sore throat
Systemic reaction (other): Sore throat, sweating
Release 10 — 12 months, dose 1
Symptoms: Frequent migraines, more susceptible to colds, frequent heart issues
Healthcare visit (other): Doctors office
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Cardiac disorder | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release